Is Wave Life Sciences Ltd (WVE) overvalued? · rev $108.3M
Wave Life Sciences Ltd (WVE) is a biotechnology company listed on NASDAQ.
This page asks whether Wave Life Sciences Ltd (WVE) looks expensive on cached numbers — not a short thesis.
Latest reported WVE revenue for 2024-12-31 was $108.3M. Net income was -$97.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. WVE currently screens at market cap $1.13B.
WVE currently screens at market cap $1.13B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next WVE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the WVE stock page for the full model, not this heading.
Not investment advice.